The lawsuit claims Target hid the potential for boycotts, backlash to its inclusion initiatives from shareholders ...
Target was hit with a class action suit claiming the retailer duped investors about the company's DEI policies and tricked them into buying stock at an artificially inflated price.
Genetically modified pig kidneys begin trials for 50 U.S. kidney failure patients FDA launches clinical trials for organ ...
Celltrion launches ADC cancer drug trials in U.S. while planning additional INDs Celltrion accelerates its global drug ...